Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

STAAR Surgical Company - Common Stock (NQ:STAA)

17.02 +0.24 (+1.43%)
Streaming Delayed Price Updated: 4:00 PM EDT, Jul 1, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about STAAR Surgical Company - Common Stock

< Previous 1 2 3 4 5 6 7 8 9 Next >
Eye Lens Maker Staar Surgical Stock Sinks As Sales Drop To $49 Million, Analyst Downgrades
Staar Surgical posted a Q4 2024 revenue decline due to weak China sales. The company plans cost-cutting measures. 
Via Benzinga
This PPG Industries Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Wednesday
Via Benzinga
Teradata Posts Weak Revenue, Joins Lyft, Vertiv, Zillow And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session
Via Benzinga
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
Via Benzinga
Why Upstart Shares Are Trading Higher By Over 25%; Here Are 20 Stocks Moving Premarket
Via Benzinga
Why NASDAQ:STAA Is a Promising High-Growth Stock in the Midst of Consolidation.
Is STAAR SURGICAL CO (NASDAQ:STAA) on the Verge of a Major Breakout as a Strong Growth Stock? 
Via Chartmill
Which stocks are moving after the closing bell on Tuesday?
Let's have a look at what is happening on the US markets after the closing bell on Tuesday. Below you can find the top gainers and losers in today's after hours session. 
Via Chartmill
STAAR Surgical Reports Fourth Quarter and Fiscal Year 2024 Results
From STAAR Surgical Company
Via Business Wire
Don't overlook NASDAQ:STAA—a stock with solid growth prospects and a reasonable valuation.
STAAR SURGICAL CO was identified as a growth stock that isn't overvalued. NASDAQ:STAA is excelling in various growth indicators while maintaining a solid financial footing. 
Via Chartmill
NASDAQ:STAA, a growth stock which is not overvalued.
Despite its growth, STAAR SURGICAL CO (NASDAQ:STAA) remains within the realm of affordability. 
Via Chartmill
Despite its growth, NASDAQ:STAA remains within the realm of affordability.
STAAR SURGICAL CO (NASDAQ:STAA), a growth stock which is not overvalued. 
Via Chartmill
In the world of growth stocks, NASDAQ:STAA shines as a value proposition.
Investors should take note of NASDAQ:STAA, a growth stock that remains attractively priced. 
Via Chartmill
Exploring Staar Surgical's Earnings Expectations
Via Benzinga
Investors seeking growth at a reasonable cost should explore NASDAQ:STAA.
Looking for growth without the hefty price tag? Consider STAAR SURGICAL CO (NASDAQ:STAA). 
Via Chartmill
STAAR Surgical to Host Fourth Quarter and Fiscal Year 2024 Earnings Conference Call and Webcast on February 19, 2025
From STAAR Surgical Company
Via Business Wire
Morgan Stanley Maintains Positive MedTech Outlook Despite Setbacks in 2024, Upgrades Intuitive Surgical And Stryker, Downgrades Nevro And Glaukos
Morgan Stanley upgrades key MedTech stocks, highlighting strong demand and growth potential, while downgrading others amid company-specific challenges. 
Via Benzinga
Investors should take note of NASDAQ:STAA, a growth stock that remains attractively priced.
Investors seeking growth at a reasonable cost should explore STAAR SURGICAL CO (NASDAQ:STAA). 
Via Chartmill
STAAR Surgical to Participate in BTIG Ophthalmology Day
From STAAR Surgical Company
Via Business Wire
Analyst Scoreboard: 4 Ratings For Staar Surgical
Via Benzinga
Analyst Expectations For Staar Surgical's Future
Via Benzinga
STAAR Surgical to Participate in Stephens Annual Investment Conference (NASH2024)
From STAAR Surgical Company
Via Business Wire
CORRECTING and REPLACING STAAR Surgical Reports Third Quarter 2024 Results
From STAAR Surgical Company
Via Business Wire
STAAR Surgical to Report Third Quarter Results on October 30, 2024
From STAAR Surgical Company
Via Business Wire
STAAR Surgical Experience Center Expands to Meet Growing Surgeon Demand
From STAAR Surgical Company
Via Business Wire
A Glimpse Into The Expert Outlook On Staar Surgical Through 4 Analysts
Via Benzinga
Sidoti Events, LLC's Virtual September Small-Cap Conference
Via ACCESSWIRE
For those who appreciate growth without the sticker shock, NASDAQ:STAA is worth considering.
Don't overlook NASDAQ:STAA—a stock with solid growth prospects and a reasonable valuation. 
Via Chartmill
STAA Stock Earnings: Staar Surgical Misses EPS, Beats Revenue for Q2 2024
STAA stock results show that Staar Surgical missed analyst estimates for earnings per share but beat on revenue for the second quarter of 2024. 
Via InvestorPlace
STAAR Surgical Reports Second Quarter 2024 Results
From STAAR Surgical Company
Via Business Wire
STAAR Surgical to Report Second Quarter Results on August 7, 2024
From STAAR Surgical Company
Via Business Wire
< Previous 1 2 3 4 5 6 7 8 9 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.